Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
algorithm
AMPA receptor antibodies
amphiphysin antibodies
anti GQ1b IgG antibody
anti IgLON5
ataxia
ataxia, cerebellar
atypical
autoantibodies
autoimmune basal ganglia encephalitis
autoimmune disease
autoimmune encephalopathy
autoimmune epilepsy
autonomic dysfunction
autonomic neuropathy
basal ganglia
basal ganglia, lesion of
basal ganglia, lesion, bilateral
behavioral disorder
behavioral disorder, acute
bradykinesia
carcinoma
carcinoma of lung
CAT scan, emission, abnormal
catatonia
cerebellar degeneration
cerebral cortex
cerebrospinal fluid, oligoclonal IgG in
children
chorea
chorea, senile
choreoathetosis
Clinical Pathologic Conference(C.P.C.)
cognition
cogwheel rigidty
collapsin response mediator protein 5 IgG
complications
computers, neurologic diagnosis and
confusion
contactin associated protein like 2 antibodies
dementia
dementia, rapidly progressive
dementia, reversible
depression
dermatomyositis
diagnostic criteria
diarrhea
differential diagnosis
DPPX
DPPX, antibodies
DPPX, antibodies, encephalitis
dyskinesia
dyskinesia, facial
dystonia
dystonia, face
efficacy
electroencephalogram
electroencephalogram, abnormalities of
electromyogram
encephalitis
encephalitis, autoimmune
encephalitis, brainstem
encephalitis, etiology
encephalitis, paraneoplastic
encephalitis, viral
encephalomyelitis
encephalopathy
face, contractions
faciobrachial dystonic seizure
false negative
false positive
fasciculation
fatigue
fever
gait disorder
gamma amino butyric acid receptor antibody
gammaglobulin therapy, intravenous
gender
glutamic acid decarboxylase, antibody
glycine receptor antibodies
hallucination
hallucination, olfactory
headache
hemimyoclonic jerks
heralding manifestation
herpes simplex encephalitis
hippocampus
Hodgkin's disease
hyperekplexia
hyperhidrosis
hyponatremia
immunologic disease
immunology and the nervous system
immunosuppressive agents
immunotherapy
inappropriate antidiuretic(A.D.H.)hormone
incidence
insomnia
intellectual deficit
intellectual deterioration
Isaacs syndrome
Jakob-Creutzfeldt disease
lateropulsion
leucine rich glioma inactivated 1 antibodies
leukemia, neurologic findings assoc.with
level of consciousness, decreased
limbic encephalitis
lumbar ganglia
malignancy screen
malignancy, occult
masked facies
memory
memory, defect of recent
memory, impairment of
meningeal enhancement
mental status, abnormal
mesial temporal lobe
mesial temporal sclerosis
misdiagnosis
monoclonal antibodies
mood change
Morvan's fibrillary chorea
movement disorder
movement disorder, extrapyramidal
movement disorder, paroxysmal
MRI
MRI pattern
MRI, abnormal
MRI, false negative
MRI, FLAIR
MRI, negative
muscle twitching
myasthenia gravis, paraneoplastic
myasthenic syndrome
myelitis, transverse, recurrent
myoclonic jerks
myoclonus
myokymia
myotonia
near syncope
negative
neurexin-3 alpha antibodies
neurologic disease, diagnoses of
neurologic disease, multifocal
neuromuscular junction
neuromyotonia
neuronal cell surface antigen
neuronopathy, sensory
neuropathy, paraneoplastic
night sweats
NMDA antagonists
old age, neurology of
onconeural antibodies
ophelia syndrome
opsoclonus-myoclonus syndrome
paraneoplastic cerebellar degeneration
paresthesias
Parkinsonism syndrome
paroxysmal neurologic deficits
paroxysmal neurologic disorder
pathognomonic
pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection
peripheral nerve, lesion of
personality change
pitfalls
plasmapheresis
pleocytosis of cerebrospinal fluid
potassium channel antibodies
practice guidelines
precipitating factors
prognosis
progressive neurologic disorder
pruritus
psoriasis
psychiatric problems in neurologic disorders
psychosis
psychosis, acute
radioimmunoassay
recurrent
Red flags
remote effect of cancer on the nervous system
retinopathy
review article
rituximab
safety
screening
seizure
seizure, adult onset
seizure, dystonic
seizure, focal
seizure, psychomotor-temporal lobe
seizure, unknown origin
serologic testing
serologic testing, false negative
seronegative
sleep pathology and physiology
steroid
steroid therapy, CNS treatment and complications with
striatal encephalitis
striatum, lesion of
striatum, lesion of, bilateral
temporal lobe
temporal lobe, lesion
temporal lobe, lesion, bilateral
teratoma
teratoma, ovarian
thymoma
treatment of neurologic disorder
tremor
visual loss
weight loss
wheelchair
white matter disease
white matter disease, subcortical
wide based gait
workup
Showing articles 850 to 900 of 2250 << Previous Next >>

Concepts and Controversies in Nonketotic Hyperglycemia-Induced Hemichorea: Further Evidence from Susceptibility-Weighted MR imaging
J Magn Reson Imaging 29:699-703, Cherian, A.,et al, 2009

Spinal Cord Involvement in Balos Concentric Sclerosis
J Neurol Sci 279:114-117, Kreft, K.L.,et al, 2009

Multiple Bilateral Non-Hemorrhagic Cerebral Infarctions Associated with Microscopic Polyangiitis
Clin Neurol Neurosurg 111:904-906, Ku, B. & Shin, H., 2009

Microscopic Polyangiitis Presenting with Capsular Warning Syndrome and Subsequent Stroke
J Neurol Sci 277:174-175, Tang, C.,et al, 2009

Non-Infectious Endocarditis in a Patient with cANCA-associated Small Vessel Vasculitis
Rheumatology 48:592-594, Horino, T.,et al, 2009

Intracranial Calcifications
Applied Radiology 48-60, Makariou,E. & Patsalides,A., 2009

Frequent Hemorrhagic Lesions in Cerebral Toxoplasmosis in AIDS Patients
J Neuroimaging 19:169-173, Bhagavati, S. & Choe, J., 2009

Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009

High-Dose Cytarabine Plus High-Dose Methotrexate Versus High-Dose Methotrexate Alone in Patients with Primary CNS Lymphoma: A Randomised Phase 2 Trial
Lancet 374:1512-1520, 1477, Ferreri,A.,et al, 2009

Hearing Improvement After Bevacizumab in Patients with Neurofibromatosis Type 2
NEJM 361:358-367, Plotkin,S.R.,et al, 2009

Acute Disseminated Encephalomyelitis Following Vacicnation Against Human Papilloma Virus
Neurol 72:2132-2133, Wildemann,B.,et al, 2009

Progressive Multifocal Leukoencephalopathy After Natalizumab Monotherapy
NEJM 361:1081-1087, Linda,H.,et al, 2009

Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
NEJM 361:1075-1080, Wenning,W.,et al, 2009

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 66:403-406, 261, 262, Schweikert,A.,et al, 2009

Natalizumab and Central Nervous System Lymphoma: No Clear Association
Ann Neurol 66:261-262, Bozic,C.,et al, 2009

Risk of Dementia and AD with Prior Exposure to NSAIDs in an Elderly Community-Based Cohort
Neurol 72:1899-1905,1884, Breitner,J.C.S.,et al, 2009

Safety of Biologic Agents After Rituximab Therapy in Patients With Rheumatoid Arthritis
Rheum Int: December 2009, Mishra, R.,et al, 2009

MRI Findings Associated With Acute Liver Failure
Neurol 72:2130-2131, Fridman,V.,et al, 2009

Bilateral Thalamic Lesions
AJR 192:W53-W62, Smith,A.B.,et al, 2009

Treatment of CNS Sarcoidosis with Infliximab and Mycophenolate Mofetil
Neurol 72:337-340, Morovan,M. &Segal,B.M., 2009

Immunologic, Clinical, and Radiologic Status 14 Months After Cessation of Natalizumab Therapy
Neurol 72:396-401,392, Stuve,O.,et al, 2009

Neuromyelitis Optica and Concentric Rings of Bal� in the Brainstem
Arch Neurol 66:274-275, Graber,J.J.,et al, 2009

Neurologic Immune Reconstitution Inflammatory Syndrome in HIV/AIDS: Outcome and Epidemiology
Neurol 72:835-841, McCombe,J.A.,et al, 2009

Posterior Reversible Encephalopathy Syndrome in Neuromyelitis Optica Spectrum Disorders
Neurol 72:712-717, Maga�a,S.M.,et al, 2009

Multiple Sclerosis Therapeutics: Unexpected Outcomes Clouding Undisputed Successes
Neurol 72:1008-1015, Wiendl,H. &Hohlfeld,R., 2009

Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009

In Vivo Mapping of Amyloid Toxicity in Alzheimer Disease
Neurol 72:1504-1511, Frisoni,B.G.,et al, 2009

Diagnostic Value of N-methyl-D-aspartate Receptor Antibodies in Women with New-Onset Epilepsy
Arch Neurol 66:458-464, Niehusmann,P.,et al, 2009

Human Natural Autoantibodies in the Treatment of Neurologic Disease
Neurol 72:1269-1276, Rodriguez,M.,et al, 2009

Detection of Human Herpesvirus-6 in Cerebrospinal Fluid of Patients with Encephalitis
Ann Neurol 65:257-267,235, Yao,K.,et al, 2009

Diagnosis and New Treatment in Muscle Channelopathies
JNNP 80:360-365, Meola,G.,et al, 2009

Recurrent Pericarditis Due to Natalizumab Treatment
Neurol 72:1616-1617, Cohen,M.,et al, 2009

Fatal Case of Deer Tick Virus Encephalitis
NEJM 360:2099-2107, Tavakoli,N.P.,et al, 2009

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol 66:593-599, Boster,A.,et al, 2009

Clinicopath Conf., Eastern Equine Encephalitis
NEJM 359:294-303, Case 22-2008, 2008

Anti-Tumor Necrosis Factor Alpha-Associated Multiple Sclerosis
AJNR 26:1548-1550, Titelbaum,D.S.,et al., 2008

Assessment: The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis (An Evidence-Based Review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 71:766-773, Goodin,D.S.,et al., 2008

MR Imaging Findings in Hepatic Encephalopathy
AJNR 29:1612-1621, Rovira,A.,et al, 2008

MR Imaging of Familial Creutzfeldt-Jakob Disease: A Blinded and Controlled Study
AJNR 29:1638-1643, Fulbright,R.K.,et al, 2008

Efficacy and Safety of Oral Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase LLB Study
Lancet 372:1463-1472, Kappos,L.,et al, 2008

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008

Natalizumab Use in Pediatric Multiple Sclerosis
Arch Neurol 65:1655-1658, Huppke,P.,et al, 2008

Pseudo-Subarachnoid Hemorrhage Found in Patients With Postresuscitation Encephalopathy: Characteristics of CT Findings and Clinical Importance
AJNR 29:1544-1549, Yuzawa,H.,et al., 2008

Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008

Lymphomatoid Granulomatosis Involving Central Nervous System Successfully Treated With Rituximab alone
Arch Neurol 65:662-665, Ishiura,H.,et al, 2008

Tick-Borne Encephalitis
Lancet 371:1861-1871, Lindquist,L. &Vapalahti,O., 2008

Disease-Modifying Therapies for Alzheimers: New Drugs on the Horizon
Practical Neurology 7:16-23, Christensen,D.B., 2008

Phase 2 Safety Trial Targeting Amyloid � Production With a ?-Secretase Inhibitor in Alzheimer Disease
Arch Neurol 65:1031-1038, Fleisher,A.S.,et al., 2008

Poststreptococcal Dystonia With Bilateral Striatal Enlargement: MR Imaging and Spectroscopic Findings
AJNR 29:1276-1278, Kendi,A.T.K.,et al., 2008

Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stoke: Results of an International Phase III Trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)
Stroke 39:89-99, Adams,H.P.,Jr.,et al, 2008



Showing articles 850 to 900 of 2250 << Previous Next >>